Article talks about setting an academy in Ahmedabad To Set Up Global Academies In Ahmedabad, Hyderabad
-
“Ensuring good manufacturing practices is now a priority over pricing,” said Jain. Prices of pharma drugs are about 65% lower in India than in other big countries, Jain said, citing a study by IPA. Hence, the body has dealt with the pricing already, according to him. However, IPA is planning to improve its partnership and supply chain with the US to make drugs more affordable in both nations.
-
The overall percentage of OAIs on Indian pharmaceutical companies had halved to 13% in 2023 from 26% in 2014. Although gaps in practices, maintenance of facilities and ancillaries, and investigations not being done versus the written procedures have risen to 23%, there is a drop of 3–4% seen in violations found in capability, training, lab controls and core manufacturing processes.
Read more at: Indian Pharmaceutical Alliance To Set Up Global Pharma Academies In Ahmedabad, Hyderabad
Disclosure: Invested in Supriya Life science, Aarti Pharmalabs and Natco Pharma.